BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25990232)

  • 41. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in antimicrobial resistance patterns of Group A streptococci, molecular basis and implications.
    Abraham T; Sistla S
    Indian J Med Microbiol; 2018; 36(2):186-191. PubMed ID: 30084408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
    Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
    J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.
    Perez-Trallero E; Urbieta M; Montes M; Ayestaran I; Marimon JM
    Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):25-31. PubMed ID: 9512178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
    Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
    J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic susceptibility pattern and erythromycin resistance mechanisms in beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates from central Taiwan.
    Lo HH; Nien HH; Cheng YY; Su FY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):613-7. PubMed ID: 24856419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.
    Kataja J; Huovinen P; Skurnik M; Seppälä H
    Antimicrob Agents Chemother; 1999 Jan; 43(1):48-52. PubMed ID: 9869564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unexpected relationships between frequency of antimicrobial resistance, disease phenotype and
    Sanson MA; Macias OR; Shah BJ; Hanson B; Vega LA; Alamarat Z; Flores AR
    Microb Genom; 2019 Nov; 5(11):. PubMed ID: 31755853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece.
    Petinaki E; Kontos F; Pratti A; Skulakis C; Maniatis AN
    Int J Antimicrob Agents; 2003 Jan; 21(1):67-70. PubMed ID: 12507840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of an erm(T) gene in strains of inducibly clindamycin-resistant group B Streptococcus.
    Dipersio LP; Dipersio JR
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):189-93. PubMed ID: 16989973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The change of macrolide resistance rates in group A Streptococcus isolates from children between 2002 and 2013 in Asahikawa city.
    Sakata H
    J Infect Chemother; 2015 May; 21(5):398-401. PubMed ID: 25618777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
    Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
    J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prevalence of erythromycin resistance in group B streptococcal isolates at a University Hospital in Taiwan.
    Janapatla RP; Ho YR; Yan JJ; Wu HM; Wu JJ
    Microb Drug Resist; 2008 Dec; 14(4):293-7. PubMed ID: 19025386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).
    Michos A; Koutouzi FI; Tsakris A; Chatzichristou P; Koutouzis EI; Daikos GL; Stathi A; Syriopoulou VP
    J Antimicrob Chemother; 2016 Aug; 71(8):2113-7. PubMed ID: 27118782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain.
    Merino Díaz L; Torres Sánchez MJ; Aznar Martín J
    Clin Microbiol Infect; 2008 Jan; 14(1):85-7. PubMed ID: 18034859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics.
    Sauermann R; Gattringer R; Graninger W; Buxbaum A; Georgopoulos A
    J Antimicrob Chemother; 2003 Jan; 51(1):53-7. PubMed ID: 12493787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrolide and Clindamycin Resistance in Group a Streptococci Isolated From Children With Pharyngitis.
    DeMuri GP; Sterkel AK; Kubica PA; Duster MN; Reed KD; Wald ER
    Pediatr Infect Dis J; 2017 Mar; 36(3):342-344. PubMed ID: 27902646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significant decline in the erythromycin resistance of group A streptococcus isolates at a German paediatric tertiary care centre.
    Farmand S; Henneke P; Hufnagel M; Berner R
    Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):707-10. PubMed ID: 21796341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continued Increase of Erythromycin Nonsusceptibility and Clindamycin Nonsusceptibility Among Invasive Group A Streptococci Driven by Genomic Clusters, United States, 2018-2019.
    Li Y; Rivers J; Mathis S; Li Z; McGee L; Chochua S; Metcalf BJ; Fleming-Dutra KE; Nanduri SA; Beall B
    Clin Infect Dis; 2023 Feb; 76(3):e1266-e1269. PubMed ID: 35684991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
    Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
    Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.